2024
Prevalence of neurological complications in children hospitalized with SARS-CoV-2 infection or MIS-C in children - single center observational study
MUŽLAYOVÁ, Patrícia, Pavlína DANHOFER, Klára ŠPANĚLOVÁ, Senad KOLÁŘ, Ondřej HORÁK et. al.Základní údaje
Originální název
Prevalence of neurological complications in children hospitalized with SARS-CoV-2 infection or MIS-C in children - single center observational study
Autoři
MUŽLAYOVÁ, Patrícia (703 Slovensko, domácí), Pavlína DANHOFER (203 Česká republika, domácí), Klára ŠPANĚLOVÁ (203 Česká republika, domácí), Senad KOLÁŘ (203 Česká republika, domácí), Ondřej HORÁK (203 Česká republika, domácí), Jozef KLUČKA (703 Slovensko, domácí), Petr ŠTOURAČ (203 Česká republika, domácí), Jan ŠENKYŘÍK (203 Česká republika, domácí), Miriam MALÁ (203 Česká republika, domácí) a Lukáš HOMOLA (203 Česká republika, domácí)
Vydání
Ceska a slovenska neurologie a neurochirurgie, PRAGUE, Czech Medical Association J.E. Purkyne, 2024, 1210-7859
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 0.500 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001296098700001
Klíčová slova anglicky
SARS-CoV-2 infection; MIS-C - children; neurological complications; epidemiology
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 2. 9. 2024 12:11, Mgr. Tereza Miškechová
Anotace
V originále
Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused the enduring global COVID-19 pandemic, which has already begun in late 2019. The virus affects various organs, including the nervous system. This study investigates neurological complications in children with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in the South Moravia region (Czech republic), where a high COVID-19 rate among children (35.790/100.000) allows for a comprehensive analysis. Methods: Data from the University Hospital Brno (from March 2020 to February 2022) were analyzed to study two groups of hospitalized children diagnosed with COVID-19 or MIS-C: one experiencing neurological complications, and the other without neurological symptoms. The analysis included demographics, admission reasons, infection severity and progression, objective neurological findings, hospitalization details, MIS-C presence and therapies used. Descriptive statistics and statistical testing were employed to assess how individual factors influenced neurological complication rates within these groups. Results: Among 420 hospitalized children with COVID-19 or MIS-C, 26 (6.2%) had neurological complications. Preexisting neurological deficits increased the likelihood of worse outcomes (P = 0.0224). Significant differences in hospitalization length (P = 0.0012), infection severity (P = 0.0052), and outcome (P < 0.0001) occurred between groups. Conclusion: Continuous monitoring and further research on neurological complications in children with COVID-19 or MIS-C are crucial for better understanding of the course of the disease and minimize complications after infection.